Noumi Limited · ASX:NOU
Noumi — Investor Presentation (February 2025)
27 slides from Noumi's investor presentation, Feb 25, 2025
Slide 1: Noumi Limited H1 FY25 Results
Noumi Limited H1 FY25 Results 25 February 2025
Slide 2: Important notice and disclaimer
Important notice and disclaimer Summary Information Only This presentation criteria contains general information about Noumi Limited and its consolidated entities (“Noumi Limited”) a nd its activities current as at the date of this presentation. It is provided in summary and does not purport to be c
Slide 3: Agenda
Agenda H1 FY25 OVERVIEW 01 COMPANY EVOLUTION COMPANY EVOLUTION 02 FINANCIAL PERFORMANCE 03 STRATEGY STRATEGY 04 CLOSING REMARKS 05 Noumi Limited | H1 FY25 Results
Slide 4: H1 FY25 Overview
H1 FY25 Overview Noumi Limited | H1 FY25 Results 4
Slide 5: Improved operating results
Improved operating results Reset, Transform, Grow strategy drives performance. Adjusted operating EBITDA of $27.5m up 19.0% Plant-based Milks delivers record adjusted operating EBITDA of $25.3m up 9.2% Market leading Milklab brand continues to grow across both plant and dairy - domestic and export -
Slide 6: Our team development
Our team development Ongoing initiatives to enhance the health and safety of team members remain a priority Our global team of over 500 highly skilled professionals, including our team in Singapore and China, drive our ongoing growth and development Increased participation in our leadership program
Slide 7: Highlights
Highlights $27.5m $4.6m $25.3m Adj Op Dairy & Nutritionals Plant-based Milks EBITDA 1,2 Adj Op EBITDA Adj Op EBITDA $4.4m $2.4m $2.2m $299.3m $206.1m $93.2m Net Dairy & Nutritionals Plant-based Milks Revenue Net Revenue Net Revenue $2.6m $3.1m $5.7m ($82.1m) Statutory net loss after tax $54.4m 1. Ad
Slide 8: Company's Transformation and Evolution
Company’s Transformation and Evolution Noumi Limited | H1 FY25 Results 8
Slide 9: Executing against the strategy
Executing against the strategy Reset progress – Remaining legacy item set for resolution Transformation progress – Dairy and Nutritionals adjusted operating EBITDA doubled in H1. More consistent operations although margin pressure remains. Transformation next steps – Increased focus on value-added o
Slide 10: Noumi – Key manufacturing sites
Noumi – Key manufacturing sites Dairy & Nutritionals Plant-based Milks Shepparton, VIC Ingleburn, NSW • Noumi Nutritionals is a leading Australian • Our state-of-the-art facility in Ingleburn, manufacturer of quality long-life dairy New South Wales specialises in the products and premium protein ing
Slide 11: Noumi Brands
Noumi has a broad portfolio of strong Noumi Brands brands that meet differing consumer needs and occasions across multiple markets. Noumi Limited | H1 FY25 Results 11
Slide 12: Financial Performance
Financial Performance Noumi Limited | H1 FY25 Results 12
Slide 13: H1 FY25 Earnings
H1 FY25 Earnings $ million H1 FY25 H1 FY24 Change($) Net revenue 299.3 296.7 2.6 Net revenue up 0.9% – Milklab overall sales up 6.7%; Domestic Long-life dairy up 7.0% and plant-based export sales up 26.6% Adj operating EBITDA1, 2 27.5 23.1 4.4 Non-operating items incl. restructuring & (6.7) (0.1) (6
Slide 14: Financial Performance | Plant-based Milks
Financial Performance | Plant-based Milks Financial results Summary of performance $ million H1 FY25 H1 FY24 Change Change Net Revenue 93.2 87.5 5.7 6.6% Record earnings, record revenues, strong margins Adjusted Operating EBITDA1,2 25.3 23.1 2.2 9.2% Adjusted Operating EBITDA Margin % 27.1 26.5 - 0.
Slide 15: Financial Performance | Dairy and Nutritionals
Financial Performance | Dairy and Nutritionals Financial results Summary of performance $ million H1 FY25 H1 FY24 Change Change Positive adjusted operating EBITDA in H1 FY25 of $4.6m, $2.4m Net revenue 206.1 209.2 (3.1) (1.5%) improvement on H1 FY24 Net revenue excl. traded milk 194.9 206.6 (11.7) (
Slide 16: H1 FY25 Balance Sheet
H1 FY25 Balance Sheet Cash and Borrowings Cash at bank of $26.5m with undrawn finance facility of $10m $ million 31 Dec 2024 30 Jun 2024 Change ($) provides liquidity for operations based on current conditions and expectations Cash and cash equivalents 26.5 14.6 11.9 Financial debt (excl. Convertibl
Slide 17: Cash Flow
Cash Flow Summary $ million 31 Dec 2024 31 Dec 2023 Cash flow from continuing operations 40.1 10.0 Net cash flow from operations very strong. Significant turnaround in collections. Trade receivables down $17m compared to Dec 23 Net finance costs (9.8) (9.4) Property plant and equipment (2.1) (2.2) W
Slide 18: Strategy
Strategy Noumi Limited | H1 FY25 Results 18
Slide 19: Our Growth Strategy
Our Growth Strategy Develop high quality and innovative dairy and plant products to meet the different nutrition and taste needs of customers and consumers across life stages Complete the Accelerate Deliver Embed Strategic Future Growth Pillars Dairy & Nutritionals Plant–based Milks world class High
Slide 20: Strategy | Plant-based Milks
Strategy | Plant-based Milks Focus Areas Accelerate investment in brand and marketing activities for Milklab and Australia’s Own in the Australian market Leverage Milklab brand campaigns, ambassador partnerships and high-quality range to increase sales and distribution Invest in R&D to deliver high
Slide 21: Strategy | Dairy & Nutritionals
Strategy | Dairy & Nutritionals Focus Areas Invest further in Noumi’s premium brands as consumer demand for high-quality Dairy and Nutritional products grow Continued focus on delivering high levels of operational efficiency to reduce wastage and increase margin Maintain focus on our supply chain, q
Slide 22: The Healthier Tomorrow Plan
lthier plane The Healthier ea t H Tomorrow Plan We aim to continuously improve our environmental er lifesty footprint for future generations. thi al l Focus areas es He We aim to create products to improve Waste and Packaging consumers’ and communities’ • We are minimising the waste we nutritional a
Slide 23: Trading Outlook
Trading Outlook In H2 FY25, Noumi expects to continue to consolidate the progress it has made in the past two years through its focus on execution of its strategy across products, channels and geographies. In the Plant-based Milks segment, Noumi is investing in the continued growth of its Milklab br
Slide 24: ESS) AOumiL
ESS) AOumiL 6 ~ / Imagining a healthier tommorrow,
Slide 25: Appendices
Appendices Noumi Limited | H1 FY25 Results 25
Slide 26: Profit and Loss Summary
Profit and Loss Summary Significant items impacting EBITDA2 $ million 31 Dec 2024 31 Dec 2023 31 Dec 2024 31 Dec 2023 1 Adjusted operating EBITDA 27.5 23.1 Onerous contracts provision - - 2 Significant items impacting EBITDA (6.7) (0.1) Restructuring expenses - - Adjusted EBITDA 20.8 23.0 Other liti
Slide 27: Noumi – Imagining a healthier tomorrow
noumi Imagining a healthier tomorrow